Severity
Low
FDA Drug recall · Reported January 25, 2017
Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).
Town and Country Compounding and Consultation Services, LLC recalled HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & … - a low-severity action.
HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & … was recalled by Town and Country Compounding and Consultation Services, LLC in January 25, 2017. Reason: Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).. Check the official notice for the remedy. Verify recall #D-0436-2017 with the FDA Drug before acting.
The recall
Town and Country Compounding and Consultation Services, LLC issued this low-severity FDA Drug recall-Subpotent Drug: due to failed potency results of 74% (spec. 80-125%)..
Sourced from official FDA Drug enforcement records. Verify recall #D-0436-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0436-2017) was formally reported on January 25, 2017, with the manufacturer initiating the action on October 18, 2016. It is classified under Low severity (Class III), with a current status of Terminated. Town and Country Compounding and Consultation Services, LLC is listed as the recalling firm, operating out of Ridgewood, NJ. Federal records list the affected scope as 101 vials.
The documented reason for this recall is: Subpotent Drug: due to failed potency results of 74% (spec. 80-125%). Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
101 vials
Related Recalls
6
5 from same agency
HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106 Prospect St - 1st FL, Ridgewood, NJ 07459
Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0436-2017 |
| Date reported | January 25, 2017 |
| Date initiated | October 18, 2016 |
| Recalling firm | Town and Country Compounding and Consultation Services, LLC |
| Firm location | Ridgewood, NJ |
| Affected scope | 101 vials |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported January 25, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.